Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
117,125,812
-
Total 13F shares
-
5,656,495
-
Share change
-
+459,079
-
Total reported value
-
$2,897,996
-
Put/Call ratio
-
5.6%
-
Price per share
-
$0.51
-
Number of holders
-
28
-
Value change
-
+$187,861
-
Number of buys
-
14
-
Number of sells
-
8
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q4 2022
As of 31 Dec 2022,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,656,495 shares.
The largest 10 holders included
MMCAP International Inc. SPC, Mirae Asset Global Investments Co., Ltd., Tejara Capital Ltd, Vident Investment Advisory, LLC, GOLDMAN SACHS GROUP INC, BANK OF MONTREAL /CAN/, ADVISOR GROUP HOLDINGS, INC., JANE STREET GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Marble Harbor Investment Counsel, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.